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ABSTRACT

Comparison of Cytokine Expression and Bacterial Growth During Periparturient and
Mid-Lactation Mastitis in a Mouse Model
Rhonda Nicole Chronis
Department of Microbiology and Molecular Biology, BYU
Master of Science

Clinical cases of bovine mastitis are most severe in the early stages of lactation. The causes of
this increased propensity for severe mastitis during early lactation, compared to mid and late
lactation are unclear. In order to better understand the early lactation immune response to
mastitis, a murine model of mastitis was employed. Intramammary inoculation of a mastitis
causing Escherichia coli strain was performed in lactating mice at various stages of lactation to
model the immune response seen in cows during lactation. In our experiments, mice in the early
stages of lactation exhibited altered mRNA expression of cytokines IL-1β, IL-6, IL-10, and
TNFα over the course of infection when compared to mice at mid-lactation. Additionally,
increased bacterial growth was observed in the mammary gland of mice infected during early
lactation compared to late lactation. These results are consistent with the immune response
observed in cows at early lactation. These results suggest that the mouse may provide a useful
model to study differences in the immune response seen during different times in lactation.
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INTRODUCTION

Mastitis
Inflammation of the mammary gland, known as mastitis, is a common disease of
mammals. Mastitis is the result of an inflammatory response in the mammary gland due to
trauma, metabolic and physiologic changes, or most commonly as the result of an infectious
pathogen (1). Between 10-30% of lactating women are affected by mastitis (2). Additionally,
mastitis is the most common and costly infectious disease of the dairy industry, resulting in a
multibillion dollar economic loss each year (3, 4). The costs associated with bovine mastitis are
the result of treatment, decreased milk production, culling, and death (5), with mastitis being the
leading cause of death in adult dairy cows (6). Over the past century, dairy cattle have been
genetically selected to maximize milk production. However, this singular focus on maximum
milk production has had a negative effect on the cow’s ability to resist mastitis (7). The increased
incidence of mastitis in commercial dairy herds has contributed to the overuse of antibiotics
which has in turn contributed to the emergence of antibiotic resistant bacteria, which are a public
health concern (8).
Mammary gland infections in cows are caused by a wide variety of organisms; these
include bacteria, mycoplasma, yeasts, viruses and even algae, with bacteria being the most
common (9). Infectious agents that cause mastitis are typically classified as contagious or
environmental. Contagious pathogens are those that are adapted to survive within the host,
establish subclinical infections, and spread from cow to cow (often via contaminated milking
equipment). The most common contagious pathogens include: Acholeplasma laidlawii,
Mycoplasma agalactiae, Mycolplasma bovigenitalium, Mycoplasma bovirhinis, Mycoplasma
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mycoides, Pasteuralla haemolytica, Streptococcus agalactiae and Staphylococcus aureus, with
S. aureus being the predominant mastitis causing pathogen in this group (9). In contrast,
environmental pathogens are opportunistic organisms that are often not well adapted to survive
long term within the mammary gland. These pathogens commonly cause acute disease, and are
then rapidly eliminated by the host immune system (5). The past several decades has seen a
dramatic reduction in incidence of mastitis caused by contagious pathogens such as S. aureus.
This has indirectly led to an increased percentage of clinical mastitis cases caused by
opportunistic pathogens such as Campylobacter coli, Pseudomonas aeruginosa, Streptococcus
uberis, and Escherichia coli (9). Currently, infections from Escherichia coli (E. coli) are the
leading cause of acute mastitis in dairy cattle (9, 10). Infections from E. coli can induce a severe
clinical case of mastitis that can cause extensive tissue damage to the mammary gland and in
some cases death (11). Due to the environmental prevalence of E. coli, this pathogen remains a
persistent threat to the dairy industry (12).
In the past, differences in disease severity of mastitis infections has often been attributed
to cow factors rather than differences in bacterial virulence (13). Although differences in the
immune response seen in individual cows certainly plays a role in disease progression and
severity, recent research strongly indicates that mammary pathogenic E. coli (MPEC) likely
express a different complement of genes compared to other E. coli pathotypes. Potential MPEC
virulence factors include type six secretion systems, long polar fimbriae and a ferric dicitrate iron
acquisition system (14-16). These virulence genes may allow bacteria to thrive in specific niches
within the mammary gland, such as the gland cistern, milk tubules and alveolar epithelium (17).
While mastitis caused by E. coli has been subject to extensive epidemiological studies, the
genetic analysis of MPEC virulence remains limited.
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Immune System
The immune system is a tightly regulated host defense system. Physical barriers, such as
skin, prevent pathogens from invading the host. Once the invading organism breaches these
barriers they are met by an array of innate immune defenses. The innate immune response is a
rapid non-specific response that does not result in long lasting immune protection (18). However,
components of the innate immune system interact with the adaptive immune system, presenting
antigens that initiate immunological memory. Immunological memory provides for a stronger
and faster immune response when a pathogen is encountered a second time. The activation and
duration of both the innate and adaptive immune system is also regulated by increases and
decreases in production of pro- and anti-inflammatory cytokines. Dysregulation of the immune
system results in unrestricted growth of microbes and accompanying host pathology.
Mammary Gland Immunology
There are several aspects of physiology and immunity that play a role in prevention and
recovery from a mastitis infection. Before an infectious agent can cause disease, it must first gain
access to the lumen of the mammary gland via the teat canal. The teat canal is sealed between
milkings in an effort to prevent bacterial colonization of the mammary gland (19). After milking,
it takes about two hours for the teat end to reseal and close the canal, leaving the mammary gland
vulnerable to microbial invasion (20). Once in the mammary gland, bacteria must overcome the
antimicrobial defenses of the gland to establish disease. If cattle are unable to eliminate the
infectious agents, bacterial will grow in the mammary gland, ultimately resulting in damage to
the mammary epithelium. Effective immune protection of the mammary gland is highly
dependent on the innate immune system (1, 5, 10, 19-72). Conserved features found on invading
pathogens, known as pathogen-associated molecular patterns (PAMPS), stimulate this innate
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immune response. These features include lipopolysaccharide (LPS), peptidoglycan, methylated
DNA, and the negative charge found on the outer membrane of bacteria. Recognition of PAMPS
by the immune system leads to inflammation and the recruitment/stimulation of immune cells
and production/activation of soluble effector molecules (21).
Cellular Defenses
Cellular defenses of the mammary gland play a vital role in limiting the severity and
duration of an infection. The resident and recruited leukocytes of the mammary gland include
neutrophils, macrophages and lymphocytes. In a healthy lactating mammary gland, macrophages
are the dominant cell type in milk and tissues (1, 3, 5, 10, 11, 22). During a bacterial infection,
macrophages phagocytize invading bacteria and kill them with proteases and reactive oxygen
species (ROS). Macrophage numbers during an infection remain relatively constant in the
mammary gland. However, they play a vital role in secreting soluble effectors that enhance
migration and antibacterial activity of neutrophils (22). Macrophages also function as a
component of the adaptive immune system, by presenting phagocytized bacterial antigens on
MHC II receptors to stimulate the CD4+ Th1 response (24, 25).
Neutrophils are thought to be the most important cell type of the innate immune response
in the mammary gland (26). During the early stage of an infection, neutrophils are recruited to
the mammary gland by a variety of inflammatory mediators such as cytokines, chemokines and
complement, expressed by resident immune cells. During an infection, greater than 90% of the
leukocyte population found in mammary tissue and milk are neutrophils (26). The importance of
neutrophil mediated protection of the lactating mammary gland is illustrated by a study
indicating that the magnitude of an E. coli mastitis infection is directly related to the rate of
bacterial growth in vivo prior to the influx of neutrophils (27). Experimental mastitis studies have
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shown neutrophils are recruited to tissues infected with E. coli approximately 1-2 hours
following exposure to infectious agent (22).
Neutrophils kill bacteria in multiple ways, including through phagocytosis and
intracellular killing, as well as through the release of bactericidal proteins. Phagocytosis of
bacteria by neutrophils is facilitated by opsonizing agents such as antibodies, complement and
cytokines. The bactericidal effect of neutrophils is mediated through proteases and respiratory
bursts that produce ROS (28). Interestingly, milk neutrophils have been shown to have lower
ROS activity than blood neutrophils (29). However, excessive inflammation attributed to
neutrophil activity in the mammary gland often results in host tissue damage and decreased milk
production (34).
Soluble Defenses
Soluble factors are an important line of defense in the mammary gland. The innate
soluble factors present in the mammary gland play a critical role in combating invading
pathogens. Many of these soluble defenses are classified as antimicrobial peptides, these proteins
directly inhibit growth or cause death of invading microbes. Antimicrobial peptides known to be
important in immune protection of the lactating mammary gland include lactoferrin and
lysozyme. Antimicrobial proteins function in a variety of ways, including iron sequestration and
inhibiting cell wall biosynthesis (30, 35).
Cytokines are produced by many different cell types in the mammary gland and have
been shown to have overlapping activities as regulators of the proliferation and differentiation of
immune cells (18, 31). Cytokines present in the milk and mammary gland are critical in
orchestrating the immune response needed to clear a microbial infection (31). There are four
major groups of cytokines: interleukins (IL), interferons (IFN), colony-stimulating factors (CSF),
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and tumor necrosis factor (TNF). Table I provides a brief overview of the cytokines known to be
expressed during a mammary inflammatory response and their observed effects. These cytokines
are critical for an efficient and effective immune response and in the clearance of invading
pathogens. Proinflammatory cytokines expressed during a mammary gland infection and known
to be critical during an immune response include IL-1β, TNF-α, IL-6, IFN-γ, IL-2, and G-CSF
(18).
Previous research has shown that a number of proinflammatory cytokines are critical to
effective mammary gland immune responses (36). During an E. coli infection, there is a sharp
increase of IL-1β levels, which is associated with the influx of neutrophils (36). Pro-IL-1β is
secreted by activated macrophages, resulting in increased body temperature and circulating
acute-phase proteins (37). Additionally, IL-1β receptor binding activates signal transduction of
various mediators, which promote kinase activation, resulting in the activation of NF-κB and
MAP kinase dependent nuclear factors (37).
IL-6 is secreted by T and B lymphocytes, monocytes, fibroblasts and activated
macrophages (38). IL-6 bound to its receptor activates the JAK/STAT pathway (37). Stimulation
of bovine mammary gland epithelial lines with LPS induces IL-6 (39), and in mammary glands
infected with E. coli, IL-6 expression has been detected as early as eight hours post infection
(40). It has been suggested that IL-6 facilitates the inflammatory process in transitioning from
the influx of neutrophils to monocytes, which is essential for the appropriate immune response to
decrease the potentially harmful effect of neutrophils (41).
TNF-α expression is significantly increased during coliform mastitis, and in LPS infused
mammary glands (42, 43). TNF-α plays a critical role in the immunological response of the
mammary gland to coliform mastitis by recruiting and activating neutrophils and elevating levels
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of nitrite and nitrate, which aid in the killing of invading pathogens (44). Macrophages secrete
TNF-α upon stimulation. TNF-α inhibits expression of TLR4 on monocytes in conjunction with
an IL-6 increase and enhances neutrophil superoxide production (37, 45, 46).
Following a robust inflammatory response and clearance of invading pathogens, a new
set of regulatory cytokines are expressed. These cytokines are anti-inflammatory and act to
repress the immune response and prevent tissue damage. IL-10 is a strong anti-inflammatory
cytokine, which mediates decreased proinflammatory cytokine response. IL-10 is secreted by
activated T cells, monocytes/macrophages, mast cells and keratinocytes (37).
The appropriately timed expression of these cytokines is key to an effective immune
response and previous research has shown that the acute symptoms of a mastitis infection are
often the result of rapid growth by the invading organism combined with an inappropriate pro
inflammatory response (18). Controlling the delicate balance of a strong proinflammatory
response to kill invading pathogens, that is also limited in duration, is key to an effective and
safe immune response.
Tissue Damage
Mammary gland tissue damage occurs as the bacterial load increases, toxins accumulate
and excessive inflammation occurs. The mammary gland alveoli begin to lose their structural
integrity and visible changes to milk and mammary gland occur (35). Mammary epithelial cells
are damaged during mastitis by a variety of mechanisms, including the release of cellular and
extracellular products from the invading bacterial pathogens, ROS and lysosomal enzymes
released by phagocytes, and by the release of proteases and cytokines during the
proinflammatory immune response (47). In mild and moderate cases of E. coli mastitis there is
minimal alveolar tissue damage. However, in severe E. coli mastitis there is a significant amount
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of necrosis of the mammary epithelium (48). Unrestricted neutrophil activity promotes tissue
damage within the mammary gland by ROS production and degranulation (26). Direct damage to
epithelial cells, as a result of neutrophil activity, has been shown by Mehrzad when mastitic milk
was co-incubated with healthy mammary tissue resulting in tissue degradation (49).
Additionally, proinflammatory cytokines such as TNF-α and IL-1 can induce apoptosis in bovine
and human mammary endothelial cells (50).
Apoptosis and necrosis of tissues occurs during an infection in response to a variety of
inducers, such as cytokines and bacterial toxins (51). The apoptosis of cells is tightly regulated
by a cascade of signaling events that involve both pro-apoptotic and anti-apoptotic factors. These
regulators include pro-apoptotic factors Bax, Bak, Bad, caspase-1 and anti-apoptotic factor Bcl2. Pro-apoptotic proteins promote permeabilization of the mitochondrial membrane and release
of ROS (52). Bcl-2 is localized on the mitochondria membrane and functions by inhibiting ROS
species activity. Increases in expression of Bax and caspase-1 and a decrease of expression of
Bcl-2 have been demonstrated in bovine mammary gland infections with E. coli (53).
Early and Late Lactation
It has been well established in dairy cattle that the efficiency of the mammary gland
immune response is directly related to the stage of lactation (56-72). Studies have shown over
50% of clinical mastitis cases occur around the time of parturition, and of those that are severe,
25% of will result in culling or death (56). A similar pattern of severe mastitis occurring shortly
after birth and less severe mastitis occurring latter in lactation is also seen in other mammals
such as goats and humans. (2, 56).
Clinical coliform mastitis is rare during mid to late lactation and is most severe during the
first few weeks of lactation (11). Previous studies have shown that during mid-lactation E. coli
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were promptly eliminated without causing damage to the mammary tissues. However, E. coli
infections during the periparturient time resulted in severe infections (60). This increased
susceptibility to clinical coliform mastitis has been hypothesized to be related to the changes in
composition, magnitude and efficiency of the mammary gland immune response. There has been
an overwhelming amount of evidence of the immunological dysfunction of neutrophils and
lymphocytes in periparturient cattle (22, 61-69). Additionally, previous research has shown that
during the periparturient period CD4+ T cells produce less proinflammatory cytokines and more
anti-inflammatory cytokines than CD4+ cells during the later stages of lactation (70).
Cytokine production at different stages of lactation has been widely studied. Monocytes
during the periparturient period produce higher levels of TNF-α than monocytes isolated at mid
to late lactation (71). The higher levels of this potent mediator at early lactation may contribute
to the severe acute inflammatory response in the mammary gland during coliform mastitis. IL-2
produced by T-lymphocytes is responsible for the clonal expansion of the T-lymphocytes during
the initial stages of infection. Studies have shown that around parturition, IL-2 activity was low,
correlating to the decreased cell function and increased susceptibility to mastitis during this
period (72).
Although the differences in mastitis severity between cows infected early or late in the
lactation cycle has been well documented, the causes of this are not well understood. The cost of
large animal models as well as the lack of immunology reagents and knockout bovine animal
lines has limited the understanding of the immunological differences occurring at early and midlactation. To further our understanding of the differences in immune response at varying stages
of lactation a small animal model is required.
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Mouse model
In the 1970s, Chandler developed and characterized an experimental mouse model of
mastitis (73). This model is comparatively inexpensive and uses standard laboratory animal
facilities. The mouse mammary gland provides the unique environment for the bacteria to grow
in milk and interact with the host cells and immune components. Bacterial counts, as well as
neutrophil numbers and histological changes are similar in bovine and murine mastitis (9, 73).
The mouse possesses five pairs of mammary glands that are functionally and
anatomically independent from each other. Each gland has only one teat opening and one ductal
gland. The glands are identified from head to tail by a letter and number depicting their relative
position. Glands L4 and R4 (fourth on the left and fourth on the right respectively) are typically
used for intramammary infections because they are the largest and easiest to observe and harvest
(74).
In addition to the similarities listed above, there are some differences between the
mammary glands of cows and mice. Milk composition between the species differs in terms of
protein, fat and carbohydrates and the bovine udder contains more resident phagocytic cells than
the murine mammary gland (75). Milk collection is also a difficult procedure in mice and
assessing the intensity of inflammation is done indirectly by observing tissue damage.
Results obtained from experiments with mice are not directly applicable to cattle and
require final assessment in cows. However, studies in mice are highly indicative of outcomes in
cattle. The accessibility of large numbers of experimental animals allows the screening of a
variety of potential antimicrobial compounds in mice where similar experiments in cows would
be expensive and time-consuming (9). Statistical significance is also achieved with a smaller
number of mice due to the use of genetically identical animals.
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The capability of the murine mastitis model to replicate bovine mastitis observed during
mid-late lactation has been well-documented (76-83). However, to our knowledge, the mouse
model has not been used to compare potential differences in the immune response of mice
infected during early and mid-lactation.
Experimental Approach
The purpose of this study was to determine if a mouse could be used to model the
immunological differences observed in cows infected with E. coli at early and mid-lactation. The
mouse lactation cycle is typically three weeks, in this study I have chosen to use 24-36 hours
post-partum as an early lactation time point and 10-11 days post-partum as the mid-lactation time
point. I hypothesized that a mouse model of early and mid-lactation mastitis, would accurately
represent the immunological differences seen in cows during early and mid-lactation.

MATERIALS AND METHODS

Bacterial Strains
Twenty E. coli strains, isolated from cows exhibiting clinical cases of mastitis, were
obtained from Cornell University. Preliminary work in wax moth larvae showed an E. coli strain
(designated M12) exhibited high virulence and was chosen to be used in these experiments. All
bacteria were grown at 37˚C in Luria Broth (LB) overnight and subcultured in fresh media to an
O.D. of 1 using an absorbance of 600nm. This culture was then diluted in sterile PBS until the
desired concentration of 4x103 CFU/mL was reached. The number of bacteria used in each
inoculum was confirmed by plating on LB agar and counting colony-forming units (CFU)
following overnight incubation. To ensure a uniform dose in each injection, a stock of E. coli,
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strain M12, was frozen in phosphate buffered saline (PBS) and used in all mammary gland
injections. The number of bacteria recovered from mammary glands, post infection was
determined by serial dilution of mammary homogenates followed by plating on LB agar.
Intramammary Inoculation
Lactating BALB/c mice between 9-12 weeks of age were used in all experiments. To
replicate the early lactation time observed in other mammals, lactating mothers 24-36 hours postpartum were used. Lactating mothers 10-11 days post-partum were chosen for the mid-lactation
stage. Mice were infected based on the method described by Brouillette (74) with slight
modifications. Briefly, mice were anesthetized using 75μl-100μl of a ketamine/xylazine solution.
A 50μl volume of bacteria (~200 CFU) in PBS was then injected directly into the lumen of the
L4 and R4 mammary glands. Injections were performed using a 33G needle with a beveled end.
Control mice were inoculated with 50µl of sterile PBS in both L4 and R4 glands. All protocols
were approved by IUCAC, Brigham Young University (protocol number 140303).
RNA Isolation
Mice were sacrificed at various times post infection and dissected to expose the
mammary glands. Lymph nodes in L4 and R4 glands were excised and mammary glands were
removed and homogenized in 1mL sterile PBS. 100µl of homogenate was then used for bacterial
counts by serial dilution and plated on LB agar. The remaining homogenate was centrifuged at
3,800 rpm for five minutes. Supernatant fluid was then discarded and the tissue pellet was
resuspended in 1mL RLT buffer (Qiagen RNeasy Kit) and again homogenized. RNA isolation
was then performed according to manufacturer’s instructions and frozen for cytokine analysis.
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RT-qPCR
RNA levels were quantified using the absorbance at 260nm as determined by a Nanodrop
spectrophotometer. Working solutions were prepared by dilution in sterile ddH2O to 100ng/µl.
qPCR primers were purchased from Integrated DNA Technologies and Applied Biosystems.
Catalog numbers for each primer probe set are found in Table II. ROX qPCR Mastermix was
purchased from Thermo Scientific. Primers were diluted to 30X. Multiplex qPCR reactions were
performed in a 20µl volume, 0.5µl of GAPDH and 1µl of each target gene primer were used in
each reaction. GAPDH was used as endogenous control.
Cycling conditions for RT-qPCR were as follows: 15 minutes at 60°C, followed by 15
minutes at 95°C, finished with 40 cycles of: 15 seconds at 95°C and 15 seconds at 60°C. All
reactions were performed on a StepOne Real-Time PCR System and analyzed using StepOne
Software v2.1.
Statistical Analysis
For cytokine analysis there were four control samples for both early and late lactation
groups. Each control sample was used as a reference sample to obtain RQ values. (For example:
Mouse #1 at 4 hours post infection was measured against each reference sample, resulting in four
separate RQ values.) All RQ values were then combined for each time point and averaged and
outliers removed from data set. Standard errors of the mean were calculated. Data is expressed as
the mean and standard error of the mean. Significance was calculated using t-test with a p value
<0.05 being considered statistically significant.
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RESULTS

E. coli proliferation in the mastitic mouse mammary gland
In these experiments, we sought to determine if a uniform inoculum of mastitis causing
E. coli injected into the mammary gland of mice at early vs mid-lactation would result in
different numbers of bacteria being recovered from the infected glands. In these short-term
experiments, pups were removed from lactating females immediately before infection and
remained separated for the duration of experiment. Lactating mice were sacrificed at 4, 8, 12, 16,
and 24 hours post infection and bacterial counts performed on mammary gland homogenates.
Bacterial growth in the early lactation and mid-lactation groups were similar at four and
eight hours post infection with an average increase of 3.2x10^5 CFU and 2.6x10^5 CFU
respectively, as seen in Figure 1. The number of bacteria recovered at 12 hours post infection
showed a slightly higher number of bacteria in early lactation mice compared to mid-lactation
mice, with a concentration of 1.3x10^8CFU and 1x10^7CFU/gland respectively. (These
differences; however, are not statistically significant.) At 24 hours post infection, early lactation
mice and mid-lactation mice once again had similar levels of bacterial growth in infected
mammary glands.
Pro-inflammatory cytokine expression in mammary gland of mastitic mice
The effectiveness of an immune response is highly dependent on appropriate cytokine
expression. Cytokines IL-1β, IL-6 and TNF-α are important components of the proinflammatory immune response within the mammary gland during a mastitis infection (31). In
these experiments, relative changes in cytokine gene expression were quantified by RT-qPCR at
4, 8, 12, 16, and 24 hours post infection. Gene expression was determined by comparison of
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infected tissues to mammary gland tissue from non-infected mice collected at the same stage in
the lactation cycle. Gene expression in the calibrator sample was set to a value of one and gene
expression in experimental groups is represented as fold change, compared to the calibrator
sample. RT-qPCR analysis of mRNA isolated from mammary tissue showed that non-infected
control gland cytokine expression between early and mid-lactation mice were uniformly low
(data not shown). Cytokine mRNA levels from mice four hours post infection were also
relatively unchanged in both early and mid-lactation mice. At eight hours post infection, proinflammatory cytokine mRNA expression increased in both the early and mid-lactation groups.
Early lactation mice expressed 1.41x more IL-1β in response to infection, whereas mid-lactation
mice showed a 3.7 fold increase after infection. The differences between these two groups (early
vs mid-lactation was statistically significant (p=0.002). IL-6 had a similar difference of
expression between early and mid-lactation mice with a higher increase of expression in midlactation mice, p= 0.0005. Additionally, at this time point TNF-α mRNA expression increased in
both early and mid-lactation groups with a fold increase of 15.87 and 39.04 respectively p=
0.002 (Figure 2). The observed delay in pro-inflammatory cytokine response in mice infected
during early lactation compared to levels observed in mice at mid-lactation coincides with the
pattern of pro-inflammatory cytokine expression previously observed in mastitic cows (40, 68,
72).
At 12 hours post infection, IL-1β expression in early lactation mice was elevated to
101.54 compared to a smaller fold increase in mid-lactation mice of 6.08, p= 0.0000004. Similar
increases in expression of IL-6 and TNF-α in early lactation mice was also observed at 12 hours
post infection, as seen in Figure 2. Conversely, 16 hours post infection exhibited similar levels of
expression of IL-1β and IL-6 in both early and mid-lactation mice. TNF-α expression at 16 hours
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post infection was higher in mid-lactation mice compared to early lactation mice, p= 0.03.
Twenty-four hours post infection experiments showed early lactation mice exhibited higher
mRNA expression of pro-inflammatory cytokines than at mice in mid-lactation (Figure 2).
Nitric oxide synthase expression in mammary gland of mastitis mice
Levels of iNOS (NOS2) mRNA were measured in an effort to measure nitric oxide
synthase which is indicative of neutrophil activity (28). TNFα is a known activator of iNOS
expression (44). Results indicated that levels of iNOS in mid-lactation mice mimicked the gene
expression pattern of TNF-α in this group, with sharp increases of expression at eight and 16
hours post infection as seen in Figure 3. However, mice in early lactation had a delay in the
initial expression of iNOS, with increases observed latter in infection (12 and 24 hours post
infection). Twenty-four hours post infection results showed a significant drop in expression of
iNOS in mid-lactation mice and a rise in expression of iNOS in early lactation mice. These
fluctuations in iNOS gene expression coincide with increases and decreases of the proinflammatory cytokine TNF-α, as seen in Figure 2.
IL-10 levels are increased in early lactation compared to mid-lactation.
IL-10 is an anti-inflammatory cytokine that functions in part by downregulating the
secretion of pro-inflammatory cytokines such as IFN-γ and TNF-α (84). Appropriate IL-10
expression has been shown to prevent excessive damage to host tissues during an inflammatory
response. However, increased expression of IL-10 can also result in an inappropriate immune
response against invading pathogens, as reviewed by Cyktor (85). Gene expression of IL-10
within the mammary gland was measured by qPCR at 4, 8, 12, 16 and 24 hours post infection as
seen in Figure 4. Interestingly, at 4 hours post infection there was a significant upregulation of
IL-10 mRNA expression seen in mice at early lactation, but not mice mid-lactation. Analysis
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eight hours post infection revealed similar levels of IL-10 mRNA expression in both groups of
mice. However, at 12 hours post infection, mice in early lactation had elevated levels of IL-10
when compared to mice in mid-lactation with a fold increase of 44.60 and 5.43 respectively.
Levels of IL-10 mRNA expression at 16 and 24 hours post infection in both groups of mice
exhibited similar increases (figure 4).
Pro-apoptosis gene expression
The regulation of apoptosis during an infection is accomplished by the expression of pro
and anti-apoptotic genes. Caspase-1 and Bax induce apoptosis of epithelial cells during a
mammary gland infection (53). Importantly, levels of pro apoptotic genes are also increased
following weaning of the nursing young, as extensive cell death occurs during involution and
accompanying remodeling of the lactating mammary gland (86-88). In these experiments,
relative levels of Caspase-1 and Bax gene expression were measured at 4, 8, 12, 16 and 24 hours
post infection. Importantly, in these experiments, mice were infected with bacteria and separated
from their pups for the remainder of the experiment. Results show that in as little as four hours
post infection significant differences were observed in the levels of both Bax as well as Caspase
with mice in mid-lactation consistently expressing higher mRNA levels when compared to mice
early in lactation Figure 5.
Anti-apoptosis gene expression
Bcl-2 promotes cellular survival and inhibits actions of pro-apoptotic proteins. In these
experiments gene expression of Bcl-2 was measured by qPCR at 4, 8, 12, 16 and 24 hours post
infection and compared to control glands (uninfected). Bcl-2 gene expression in the infected
mammary gland showed significant differences in early, compared to mid-lactation mice, as
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shown in Figure 5. Throughout the course of infection, mice in mid-lactation had higher levels of
Bcl-2 gene expression in harvested tissues than the mice in early lactation.
Bacterial growth and cytokine expression in mice infected at early and mid-lactation
during normal nursing.
As discussed above, expression of inflammatory cytokines in the lactating mammary
gland appear to be altered in the infected mammary glands between the two groups of mice.
However, in the experiments described above, lactating mice were separated from their pups
following mammary gland infection. In the following experiment, mice were infected with a
standard inoculum of E. coli at both early and mid-lactation time points as described above.
However, in these experiments pups were allowed to nurse normally following infection. Results
of these experiments show that bacterial numbers as well as apoptotic gene regulation differed in
mice infected during early and mid-lactation. Mammary glands of mice infected at early
lactation time points had increased numbers of bacteria compared to mice infected at midlactation at 24 hours post infection (Figure 6).
In these experiments all pro and anti-inflammatory cytokines were elevated in infected
glands when compared to control glands following a 24 hour infection, as seen in Figure 7. Mice
in early lactation also exhibited higher gene expression of pro-inflammatory cytokines IL-1β, IL6 and TNF-α than in mid-lactation. Levels of iNOS gene expression was higher in mice in midlactation than in mice in early lactation. Anti-inflammatory cytokine IL-10 exhibited
significantly higher levels of gene expression in early lactation mice with a fold increase of
expression of 691 while mice in mid-lactation showed a fold increase of 90. Of the apoptosis
regulators, Bcl-2 was the only gene expressed at a significantly different level between early
lactation and mid-lactation mice as seen in Figure 7.
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DISCUSSION

Mastitis is the most economically costly disease of the dairy industry (3, 4). Most mastitis
infections (both in terms of severity and frequency) occur during the periparturient period (33,
56, 58, 61, 89, 90). Previous research in cows has shown impaired immune responses during this
time. Periparturient immune responses are characterized by altered cytokine production,
impaired neutrophil activity, and result in increased bacterial growth (23, 59, 62, 65, 69, 91).
Better understanding of the factors contributing to this increased risk of mastitis are needed to
design effective therapies and preventive strategies. A mouse model has not previously been
utilized to study the immune response during the periparturient period. In this study,
intramammary infusions with E. coli were performed in mice in “early lactation” (24-36 hours
post-partum) and in mice in “mid-lactation” (10-11 days post-partum). The purpose of this
research was to gain a better understanding of potential differences in the cytokine response of
mastitic animals during early and mid-lactation.
Bacterial Growth
A delay in neutrophil recruitment and rapid/uncontrolled bacterial growth in the
mammary gland is commonly associated with the periparturient period (92-97). Previous
research has determined that even a one-hour delay in neutrophil recruitment to the mammary
gland could result in up to an 8-fold higher bacterial load and accompanying higher endotoxin
concentration (97, 98). In our experiments, bacterial load (CFUs) in the mammary gland of mice
infected early in lactation (when pups were nursing) was higher than the bacterial load in mice at
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mid-lactation following a 24 hour infection (Figure 7). This increase in bacterial growth in mice
during early lactation is consistent with results seen in cows during early lactation and supports
the idea that differences in cytokine expression in early vs. mid-lactation result in varied
bacterial growth and disease pathology (56, 60).
In experiments in which mothers were separated from their pups following infection,
bacterial growth between the two groups of mice was not significantly different at any point over
the course of infection (Figure 1 and 7). The observed differences in bacterial growth at 24 hours
post infection in animals which were nursing pups vs mothers not nursing could be associated
with the lack of milk removal via nursing. Milk stasis in the lactating mammary gland may have
provided bacteria an improved environment to grow and possibly evade the immune components
present in the mammary gland, resulting in differences in bacterial growth in these experiments.
E. coli strain M12 was used in all experiments. This strain of E. coli is highly virulent,
compared to other strains. Future work in which less virulent strains of bacteria are used may
allow us to detect more distinct differences in bacterial growth between these two groups of
mice.
Proinflammatory Cytokines
The cytokines IL-1β, IL-6 and TNF-α have been shown to be critical in a bovine
mammary gland immune response and expression patterns of these cytokine have been shown to
differ in early vs. mid-lactation. (56, 99). Elevated levels of these proinflammatory cytokines
have been shown to be contributors to tissue damage and severe mastitis (68, 72). In experiments
with pups reunited with nursing dams following infection, we observed significantly increased
expression of IL-1β, IL-6, and TNF-α in the mammary tissues of mice in early lactation
compared to expression levels seen in mice at mid-lactation 24hours post infection (Figure 7).
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This increase in proinflammatory cytokine expression during early lactation is consistent with
the cytokine profile observed in bovine mastitis during early lactation (18, 40).
The immune response to bovine mastitis at the periparturient time has not been well
characterized. However, results from previous experiments using a bovine model of mastitis
suggest there may be altered expression of cytokines in periparturient cows during the initial
inflammatory response compared to cows later in lactation (40, 68, 100). The direct comparison
of cow and mouse models at each time point is difficult, due to the lack of side-by-side
experiments in cows during early and mid-lactation.
To investigate the potential of altered expression of cytokines over the course of
infection, in this study cytokine expression was measured by RT-qPCR at 4, 8, 12, 16 and 24
hours post inoculation. These mouse experiments were done with pups removed from the nursing
dams for the duration of the infection in an effort to reduce variability and ensure total retention
of the inoculum. In these experiments the proinflammatory cytokines IL-1β, IL-6, and TNF-α
were measured over the course of infection. Results indicate that mice in mid-lactation exhibited
a significant increase in IL-1β, IL-6 and TNF-α eight hours post infection compared to control
tissues. Conversely, mice in early lactation had a delay in proinflammatory cytokine expression,
which peaked at 12 hours post infection (Figure 2). In addition to exacerbated disease pathology
caused by elevated levels of proinflammatory cytokines, the observed delay in cytokine
expression in mice infected early in lactation may be a contributing factor in the delay of
neutrophil recruitment and increased severity of disease at the periparturient time.
TNF-α has been the most extensively researched proinflammatory cytokine in
experimental bovine mastitis and has been shown to be critical for an effective immune response
during a mammary gland infection (56, 65, 68, 71, 101). Monocytes isolated from cows early in
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lactation have been shown to produce higher levels of TNF-α compared to monocytes isolated
from cows in mid-late lactation (56, 71). It has also been suggested that the over-production of
TNF-α during the early stages of lactation may contribute to immunopathological changes in
host tissues, resulting in elevated bacterial growth and in some cases animal death (65, 68, 71,
72). Research in cows has shown TNF-α expression peaked at eight hours post infection in
mammary gland tissues (40, 101). Additionally, cows tested during early lactation had a delay of
TNF-α expression with peaks occurring 10-16 hours post infection (56, 72). In our experiments,
the expression pattern of TNF-α in mice at early lactation and mice at mid-lactation followed the
expression patterns previously observed in cows, with peaks of TNF-α occurring at 12 and eight
hours post infection, respectively (Figure 2). These results further confirm the validity of the
mouse model as a valuable resource to study the cytokine response during a mastitis infection at
the different stages of lactation.
The early lactation mouse model allows the unique ability to advance our understanding
of these critical cytokines at a molecular level. The mouse could provide a valuable model to
study the effect of modulating cytokine production. This could be accomplished through
blocking activity of cytokines in the mammary gland through the use of antibodies. Likewise,
enhancing levels of cytokines by the addition of exogenous cytokine in the mammary gland is
possible using the mouse model. Increasing our understanding of the role of specific pro
inflammatory cytokine responses at the periparturient time will aid in the development of
therapeutic strategies specifically targeting the high-risk early lactation time.
iNOS
Delayed neutrophil recruitment to infected mammary glands at the periparturient time is
thought to contribute to systemic disease and death in severe cases of mastitis. Correspondingly,
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cows during the periparturient period generally have minimal influx of neutrophils to the site of
infection (60). Additionally, proteomic data on cows in early lactation showed a down regulation
of histone H2A.1 in neutrophil membranes, correlating with a decrease in neutrophil function
and an increase in disease susceptibility (102). Previously published studies also indicate there is
an increase in the percentage of apoptotic neutrophils in the blood, and an increase in necrotic
neutrophils in milk in early lactating cows in comparison to mid lactating cows. These factors
are thought to increase the risk of severe mastitis during this time (103).
In these studies iNOS levels were measured in mammary tissues in an effort to determine
the level of nitric oxide synthase; a protein which is indicative of neutrophil activity (28). In our
experiments, we observed lower levels of iNOS, in the first eight hours post infection in mice
early in lactation compared to mice in mid-lactation. This reduced level of iNOS expression may
reflect decreased neutrophil recruitment and/or increased neutrophil death in mice infected in
early lactation.
Neutrophil recruitment and activation within the mammary gland is accomplished by an
assortment of chemokines and cytokines, one of which is TNF-α. Cows at mid-lactation with
mastitis displayed peaks in expression of TNF-α coinciding with peaks of expression of NO (44,
101). We also found this to be true of mice in mid-lactation with expression of TNF-α and iNOS
being tightly correlated over the course of infection (Figure 2 and 4). Mice in the early stages of
lactation did not exhibit this correlation in expression, further supporting our hypothesis of
immune impairment in the periparturient mouse (59, 102). Future experiments to more
specifically study neutrophil differences during early vs. mid-lactation include isolating
neutrophils from mice at these time points and testing neutrophil function. These experiments
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could confirm the results of iNOS measurements we observed and support our hypothesis of
neutrophil impairment in mice during the early stages of lactation.
IL-10
IL-10 is an anti-inflammatory cytokine that is essential in the regulation of the
inflammatory response. IL-10 production early in infection is thought to be produced primarily
by activated macrophages (104, 105). Autocrine and paracrine activation of macrophages
through IL-10 results in initiation of the JAK/STAT signaling pathway, resulting in downregulation of inflammatory gene expression (106-109). IL-10 functions by blocking or reducing
proinflammatory cytokine expression at different stages of the immune response (104, 110).
Resident macrophages in the mammary gland have been shown to be an important line of
defense against invading pathogens (22). Macrophages have the ability to modulate the immune
response via expression of various cytokines such as IL-1β, TNF-α and IL-10. This is thought to
occur due to the wide variety of innate immunological receptors on these cells (111, 112).
Macrophages that recognize live bacteria have been shown to adapt the electron transport chain
(ETC) of their mitochondria to increase the generation of ROS and subsequently increase the
expression of proinflammatory cytokines. Conversely, macrophages when exposed to dead
bacteria stimulated a different ETC of the mitochondria, resulting in an increase in expression of
anti-inflammatory cytokines such as IL-10 (113). These results suggest the response of the innate
immune system is dependent on activation of specific PRR and the consequent activation of
specific mitochondrial ETC that result in increased expression of pro or anti-inflammatory
cytokines.
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Macrophages play a vital role in secreting soluble effectors and stimulating the TH1
response (22, 23). IL-10 has been shown to inhibit the development of TH1 response via
activation of macrophages (104). Previous research has shown that around the time of parturition
there is a shift from a TH1 response to a TH2 response in cows (58). This shift results in a
predominantly anti-inflammatory response if an animal is infected during the periparturient time.
In agreement with this previously published observation an increase in IL-10 expression was
seen in our experiments in mice when infected early in lactation (Figure 7).
It has been hypothesized that the production of TH2 associated cytokines may serve a
protective role during disease by down-regulating the production of proinflammatory cytokines.
In the current study, a significant increase in expression of IL-10 after four hours of infection
was observed in mice in early lactation. The elevated levels of IL-10 in the initial stages of
lactation is likely not due to the predominantly immunosuppressive nature of the T helper cells at
the time of birth. Rather, this gene expression is most likely a product of resident macrophages
and epithelial cells in the mammary gland (37, 84, 114, 115). These data are supported by studies
showing macrophages from IL-10-/- mice produce high amounts of TNF-α in response to LPS
stimulation. Additionally, in IL-10 deficient macrophages stimulated with IL-10, downregulation of TNF-α was observed as early as one hour after IL-10 addition (109). To our
knowledge, IL-10 gene expression during the initial stages of a mastitis infection in
periparturient cows has not been studied. Results from the current study suggest that elevated IL10 gene expression in the initial stages of infection may be a contributing factor in the delay of
pro-inflammatory cytokine expression observed during the initial immune response of cows
infected early in lactation.
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As mentioned above, macrophages have the ability to transiently increase mitochondrial
ROS activity and scale the immune response based on the invading bacteria’s pathogenicity
(111, 112). Mouse macrophages challenged with dead bacteria decrease their production of IL1β and increase production of IL-10 (113). This might explain the increase in IL-10 production
seen in mice during mid-lactation without nursing pups 24hours post infection, as seen in Figure
4. Regular milk removal from the mammary gland likely results in the continual removal of dead
bacteria in the mammary gland. However, in experiments with weaned pups, there would be no
removal of milk (and dead bacteria) throughout the infection. I theorize that macrophages in the
gland may be sensing both viable and dead bacteria, resulting in expression of both
proinflammatory and anti-inflammatory cytokines, explaining the elevated levels of IL-10 in the
mice in mid-lactation without nursing pups.
Previous studies in mice have shown forced weaning of the young induces mammary
gland involution as early as 12 hours post weaning (115). This involution of non-infected
mammary glands resulted in elevated expression of IL-10 in this tissue (115). The differences
observed in IL-10 gene expression in mice during mid-lactation, between the nursing and
weaned experiments, may be influenced by cytokine expression changes, which occur normally
in mammary tissues during normal mammary gland involution following weaning (86-88).
Future experiments blocking the activity of IL-10 during the early stages of infection may
prevent the delay of proinflammatory cytokine expression observed in the mice in early lactation
experiments. These experiments would contribute to a better understanding of the neutrophil
influx and increased disease severity seen in previous experiments. Additionally, enhancing the
availability of IL-10 in the mice at various stages of lactation could further our understanding of
its role and importance in the immune response during an E. coli mammary gland infection.
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Bcl-2 and Inflammasomes
Bcl-2 is an anti-apoptotic protein, critical in the regulation of the inflammatory
response. This protein acts by suppressing oxidative stress signals in the cell and prevents
activation of NLRP1 and NLRP3 inflammasomes (116-119). The activation of the proinflammatory cytokine IL-1β has been shown to be directly dependent on NLRP3
inflammasomes (117). The importance of inflammasome activation is well illustrated by
experimental results showing that treatment with an experimental drug pDAG, which activates
inflammasomes, results in a decrease in the somatic cell count in milk from mastitic cows (120).
Studies in cows during mid-lactation have shown Bcl-2 expression in the mammary gland
changes over the course of an infection. Cows in mid-lactation exhibited a decrease in Bcl-2
expression 24 hours post infection, and at 72hours post infection Bcl-2 increased to levels seen in
control glands, coinciding with decreases in SCC and inflammation (53). Bcl-2 expression in
infected mammary tissues of cows during the early stages of lactation has not been well
characterized. However, studies have shown healthy mammary glands in cows in the early stages
of lactation exhibited a steady state of low Bcl-2 expression (121).
In the current study, Bcl-2 levels were measured over the course of a mastitic infection,
using mice during early and mid-lactation. Results from these experiments indicate that Bcl-2
expression is unchanged over the first 24 hours of an infection during early lactation.
Conversely, Bcl-2 expression in an infection during mid-lactation increased significantly (Figure
5). Mice in mid-lactation exhibited a peak in Bcl-2 expression at eight hours post infection, and a
sharp decrease in expression (returning to near base line levels) at 12 hours post infection. This
drop in Bcl-2 gene expression preceded an increase in IL-1β gene expression at 16 hours post
infection.

27

The inverse correlation between IL-1β and Bcl-2 expression seen during mid-lactation
suggests that elevated levels of IL-1β in mice during mid-lactation may be related to the decrease
of Bcl-2 expression in infected mammary tissues at 12 hours post infection. The regulation of
inflammatory cytokines, such as IL-1β, is a complex process with many positive and negative
regulators of expression. The fact that low expression of Bcl-2 in uninfected mice and mice
during early lactation does not lead to expression of IL-1β may be due to the combinatorial effect
of changes in expression of multiple cytokines, including Bcl-2. Conversely, this inverse
association between Bcl-2 expression and IL-1β expression may be coincidental. Future
experiments using siRNA knockdown of Bcl-2 expression in cell lines could shed insight into the
potential role of Bcl-2 in IL-1β regulation.
The initiation of the innate immune response to an invading pathogen occurs when PRR
are bound by pathogen-associated molecular patterns (PAMPS) resulting in the expression of
proinflammatory cytokines (122). IL-1β is a potent pro-inflammatory cytokine whose maturation
to its active form is tightly regulated by the catalytic activity of caspase-1. Active caspase-1
requires signal-dependent auto-activation within multi-protein complexes known as
inflammasomes (123). The NLRP3 (NOD-like receptor family, pyrin domain containing 3)
inflammasome has been shown to activate caspase-1 in response to ATP, pore-forming toxins,
crystalline substances, nucleic acids, bacterial or viral pathogens and damage-associated
molecular patterns (DAMPS) (124).
TLR4 activation of the NLRP3 inflammasome in myeloid cells is essential in the innate
immune response to gram-negative bacteria (Schroder 2010). As reviewed by Guo et al (124),
binding of TLR4 with extracellular LPS promotes activation of NLRP3 proteins, and the
upregulation of pro-IL-1Β and NLRP3 mRNA expression via NF-κΒ signaling. Activation of
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NLRP3 leads to oligomerization of other NLRP3 receptors. This clustering of NLRP3 recruits
apoptosis-associated speck-like protein containing CARD (ASC) proteins. The binding of ASC
proteins to NLRP3 recruits pro-caspase-1. Aggregation of pro-caspase-1 to the inflammasome
leads to the auto-cleavage of pro-caspase-1 to it’s the active form which ultimately cleaves proIL-1B to its active form of IL-1β (124). Formation of the inflammasome is also influenced by
potassium efflux, mitochondrial ROS generation and increased intracellular calcium levels (125128).
The activation of inflammasomes is tightly regulated to prevent inappropriate
inflammatory responses. Scavengers and inhibitors of ROS inhibit priming of NLRP3
inflammasomes and block the positive regulation of ROS on pro-inflammatory cytokine
expression (129, 133, 134). The anti-apoptotic protein Bcl-2 counterbalances oxidative damage
and up-regulates the production of anti-oxidant enzymes (130-132). Thus Bcl-2 expression can
lead to prevention of inflammasome activation and a decrease in pro-inflammatory cytokine gene
expression (133, 134). Research on the function of Bcl-2 in mastitis typically focuses on its role
as an apoptotic regulator, and not on the influence of inhibiting proinflammatory cytokine
expression through anti-oxidant abilities (47, 53, 135, 136). Inflammasome activity during a
mammary gland infection has not been well characterized, particularly during the periparturient
time.
Our experiments suggest the absence of Bcl-2 expression in mice in early lactation during
mastitis may contribute to the over-expression of potent pro-inflammatory cytokines observed in
cows and mice at the periparturient time. This lack in innate immune response regulation at the
early stages of lactation may contribute to the increased severity of disease and tissue damage,
characteristic of mastitis infections during the early stages of lactation (40, 68, 84).
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The period before parturition is characterized by extensive remodeling of the mammary
alveolar glands. Lipoproteins have been hypothesized to inhibit LPS from binding to TLR4 (137139). This may result in a delayed upregulation of IL-1β and NLRP3 mRNA via the NF-κB
signaling pathway. It is possible the lipoproteins present in the colostrum can mask LPS from
binding TLR4 and initiating the innate immune response (141). Caseins, whey proteins and
lactose synthesis enzymes are highest at early lactation compared to later stages of lactation
(142). In our mouse mastitis model, initial IL-1β gene expression was delayed in mice in the
early stages of lactation. As mentioned previously, a delay in pro-inflammatory cytokine
expression in cows at early lactation may be present in the initial stages of infection. Cows at
mid-lactation have been shown to significantly upregulate TLR4 expression 24 hours post
infusion with E. coli (140). It has been hypothesized the TLR4 signaling cascade initializing
expression of IL-1β may be dysfunctional or depressed around parturition (133). It is clear
multiple checkpoints are necessary in the regulation of IL-1β production. In the current study,
mice in early lactation exhibited an initial delay in IL-1β expression at 8hours post infection,
despite low Bcl-2 expression. I hypothesize this delay in expression may be attributed to either
IL-10 over-expression at 4 hours post infection (Figure 3), or to a dysfunctional TLR4 signaling
cascade during the initial stages of infection.
Conclusions
Results from our early lactation murine mastitis model support the hypothesis that
animals infected at different times in the lactation cycle respond with different cytokine
responses. Animals infected early in lactation were observed to express higher levels of IL-1β,
IL-6, TNF-α and IL-10 at 24 hours post infection, and low expression of Bcl-2 over the course of
the infection. Conversely, animals infected later in the lactation cycle expressed higher levels of
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iNOS, an indicator of neutrophil activity. The first eight hours of infection resulted in an increase
of anti-inflammatory cytokine expression and a delay in proinflammatory cytokine expression in
mice infected early in lactation when compared to mice infected later in the lactation cycle.
The use of small animal models has allowed substantial advances in our understanding of
diseases that plague humans as well as animals. Continually adapting these models to be more
efficient and accurate is necessary for not only furthering our understanding of the immune
response, but also for finding better and more efficient methods to combat these important
diseases. To our knowledge, expression of IL-10 and Bcl-2 in periparturient cows over the
course of infection has not been previously studied. Our results, from a mouse model of mastitis,
suggest that immune dysregulation, resulting in rapid IL-10 expression and impaired Bcl-2
modulation in periparturient animals may contribute to increased disease frequency and severity.
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Table 1: Overview of the cytokines expressed during a mammary inflammatory response and
their observed effects.

Cytokine
IL-1β

IL-2

IL-6

IL-8
IL-10
G-CSF
TNF-α
IFN-γ

Observation
• Increases neutrophil number and enhances phagocytosis and
bactericidal activity
• Influences acute phase inflammatory response
• Recruits neutrophil migration into infected mammary gland
• Promotes mononuclear cell proliferation in mammary gland
• Enhances bactericidal activities of lymphocytes
• Increase plasma cell numbers
• Activate NK cells
• Neutrophil chemoattractant
• Mediates switch from neutrophil to monocyte recruitment as an
immune suppressor
• Promotes B and T cell differentiation
• Promote Th2 and T17 response
• Strong chemoattractant
• Induces inflammation
• Down-regulate proinflammatory cytokines, MHC II expression,
and macrophage co-stimulatory molecules
• Anti-inflammatory cytokine
• Increase neutrophil numbers in blood and milk
• Increase milk somatic cell count
• Enhances bactericidal activity
• Enhance acute phase inflammatory response
• Enhance neutrophil activity
• Promotes expression of endothelial adhesion molecules
• Enhance neutrophil activity
• Activate macrophages
• Upregulates MHC II expression
• Mediates differentiation of naive CD4 T cells into Th1 effectors
As reviewed by Sordillo (34)
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Table 2: qPCR pre-designed primers were ordered from Integrated DNA Technologies.
Housekeeping gene GAPDH was ordered from Applied Biosystems.

Gene

Catalog Number

IL-1β

Mm.PT.58.41616450

IL-6

Mm.PT.58.13354106

IL-10

Mm.PT.58.23504055

Bax

Mm.PT.58.14012210

Bcl-2

Mm.PT.58.4362966

Caspase-1

Mm.PT.58.13005595

iNOS

Mm.PT.58.43705194

TNF-α

Mm.PT.58.5812575861

GAPDH

1416074
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Figure 1: Intramammary growth of E. coli following experimental challenge in early and
mid-lactating mice with pups removed. Following intramammary infusions with 200 CFU of
M12 in L4 and R4 mammary glands. Whole mammary glands were collected at various times,
homogenized and plated following serial dilutions. Data are presented as the mean ± S.E.M. n=35.
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Figure 2: Effect of intramammary challenge with E. coli on mRNA expression of proinflammatory cytokines. The expression of (A) IL-1β, (B) IL-6, and (C) TNF-α was determined
by measuring the expression of each target gene and using GAPDH as an internal reference and
converted to relative fold induction compared to non-infected control glands. Data are presented
as the mean ± S.E.M. n=3-5 at each time point in each group. P-value: *<0.05, **<0.001,
***<0.0001
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Figure 3: Effect of Intramammary challenge with E. coli on mRNA expression of iNOS.
The expression iNOS was determined at each time point. Relative fold induction of gene
expression was determined by comparing experimental to control tissues. Data are presented as
the mean ± S.E.M. n=3-5 at each time point in each group. P-value *<0.05 and ***<0.0001.
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Figure 4: Effect if Intramammary challenge with E. coli on mRNA expression of antiinflammatory cytokine IL-10. The expression of IL-10 was determined at each time point.
Relative fold induction of gene expression was determined by comparing experimental to control
tissues. Data are presented as the mean ± S.E.M. n=3-5 at each time point in each group. P-value:
**<0.001 and ***<0.0001.
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Figure 5: Effects of intramammary challenge with E. coli on mRNA expression of proapoptotic and anti-apoptotic markers. The expression of anti-apoptotic Bcl-2 (A) and proapoptotic Bax and Caspase-1 (B and C) was determined at each time point. Relative fold
induction of gene expression was determined by comparing experimental to control tissues. Data
are presented as the mean ± S.E.M. n=3-5 at each time point in each group. P-value *<0.05,
**<0.001 and ***<0.0001.
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Figure 6: Intramammary growth of E. coli following 24 hour experimental challenge with
pups nursing. Following intramammary infusions of 200 CFU of M12 into L4 and R4 glands in
early lactation mice and mid-lactation mice. Whole mammary glands were collected at 24 hour
post infection. Serial dilutions of tissue homogenates were plated and bacterial colonies counted.
Data are presented as the mean ± S.E.M. P-value <0.05, n=5-6.
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Figure 7: Effect of intramammary challenge with E. coli on mRNA expression with nursing
pups. The expression of IL-1β, IL-6, IL-10, TNF-α, iNOS, Bax, Bcl-2 and Caspase was
determined 24 hours post infection. Relative fold induction of gene expression was determined
by comparing tissues of mice infected with pups nursing and with pups weaned to uninfected
control tissues. Data are presented by mean ± S.E.M. n=5-6 for each group. P-value: *<0.05 and
***<0.0001
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